Literature DB >> 3004621

Assessment of malignancy potential in so-called interval mammary carcinomas.

A von Rosen, K Erhardt, L Hellström, A Somell, G Auer.   

Abstract

Forty-two so-called interval cancers of the breast were studied. The mammograms were reviewed and the tumors were classified as 14 'unrecognized', 9 'observer error', 1 'technical error' and 18 'true' interval cancers. By using a scoring system based upon histologic differentiation, axillary nodal status, estrogen receptor level, and nuclear DNA content, eight ductal carcinomas with high malignancy potential were identified. All of these tumors belonged to the group 'true' interval cancer. The data indicate that the mammographic subgroup 'true' interval cancer identifies the highly malignant tumors. However, even this strictly selected subgroup is heterogeneous since it also includes some tumors with low malignancy potential.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3004621     DOI: 10.1007/bf01806772

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  14 in total

1.  A photographic cytophotometric method which avoids distributional error.

Authors:  L R Adams
Journal:  Acta Cytol       Date:  1968 Jan-Feb       Impact factor: 2.319

2.  DNA content and survival in mammary carcinoma.

Authors:  G U Auer; T O Caspersson; A S Wallgren
Journal:  Anal Quant Cytol       Date:  1980-09

3.  Prognostic significance of nuclear DNA analysis in histological sections in mammary carcinoma.

Authors:  K Erhardt; G Auer; A Fallenius; A Folin; G Forsslund; C Silfverswärd; A Zetterberg
Journal:  Am J Clin Oncol       Date:  1986-04       Impact factor: 2.339

4.  Breast cancer missed by mammography.

Authors:  J E Martin; M Moskowitz; J R Milbrath
Journal:  AJR Am J Roentgenol       Date:  1979-05       Impact factor: 3.959

5.  Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans.

Authors:  G Auer; E Eriksson; E Azavedo; T Caspersson; A Wallgren
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

6.  Prognostic significance of nuclear DNA content in serous ovarian tumors.

Authors:  K Erhardt; G Auer; E Björkholm; G Forsslund; B Moberger; C Sifverswärd; G Wicksell; A Zetterberg
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

7.  Interval breast cancer: a more aggressive subset of breast neoplasias.

Authors:  R DeGroote; B F Rush; J Milazzo; M J Warden; J M Rocko
Journal:  Surgery       Date:  1983-10       Impact factor: 3.982

8.  Tumor growth, doubling times, and the inability of the radiologist to diagnose certain cancers.

Authors:  J B Buchanan; J S Spratt; L S Heuser
Journal:  Radiol Clin North Am       Date:  1983-03       Impact factor: 2.303

9.  Mammographically occult breast cancer. A pathologic and radiologic study.

Authors:  R Holland; J H Hendriks; M Mravunac
Journal:  Cancer       Date:  1983-11-15       Impact factor: 6.860

10.  Cytochemical identification of quiescent and growth-activated tumor cells.

Authors:  G Auer; J Ono; T O Caspersson
Journal:  Anal Quant Cytol       Date:  1983-03
View more
  7 in total

1.  A study of interval breast cancer within the NHS breast screening programme.

Authors:  W K Cowan; B Angus; J C Gray; L G Lunt; S R al-Tamimi
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

2.  The Stockholm breast cancer screening trial--5-year results and stage at discovery.

Authors:  J Frisell; G Eklund; L Hellström; U Glas; A Somell
Journal:  Breast Cancer Res Treat       Date:  1989-01       Impact factor: 4.872

3.  Analysis of interval breast carcinomas in a randomized screening trial in Stockholm.

Authors:  J Frisell; G Eklund; L Hellström; A Somell
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

4.  Interval cancer and survival in a randomized breast cancer screening trial in Stockholm.

Authors:  J Frisell; A von Rosen; M Wiege; B Nilsson; S Goldman
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

5.  The occurrence of interval cancers in the Nijmegen screening programme.

Authors:  P H Peeters; A L Verbeek; J H Hendriks; R Holland; M Mravunac; G P Vooijs
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

6.  The detectability of breast cancer by screening mammography.

Authors:  S Ciatto; M Rosselli Del Turco; M Zappa
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

7.  The impact of the first 3 years of breast cancer screening on the overall presentation of breast cancer.

Authors:  C Moody; A Corder; M A Mullee; P Guyer; C Rubin; M Cross; G T Royle; I Taylor
Journal:  J R Soc Med       Date:  1994-05       Impact factor: 18.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.